deltatrials

Zimmer Biomet Clinical Trials

Sponsors / Zimmer Biomet

Zimmer Biomet appears as lead sponsor on 228 trial records in ClinicalTrials.gov. The portfolio currently includes 21 recruiting studies, 40 active non-recruiting studies, and 101 completed studies. 43 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, regulatory actions. Cumulative planned enrollment across all listed trials is 50,911 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

228
Total Trials
21
Recruiting
40
Other Active
101
Completed
43
Terminated / Withdrawn
50,911
Total Enrollment

Termination reasons: Other53% · Recruitment26% · Regulatory9% · Business7% · Efficacy5%

Recent Terminations

  • NCT05497206 Phase NA Stopped Dec 2024
    Avascular Necrosis of Hip
    "The data needed for regulatory submissions based on the current pace of the study, will not be available in the foreseeable future."
  • NCT04326010 Stopped Dec 2024
    Hip Osteoarthritis
    "Data collected up to this point has provided sufficient follow-up and will allow for a reasonable estimate of the five-year survivorship rate for the Echo Bi-Metric Microplasty stem in primary total hip arthroplasty."
  • NCT05980234 Stopped Nov 2024
    Avascular Necrosis
    "Zimmer Biomet received the CE mark for the Continuum and Trilogy IT Acetabular System, which includes the Longevity IT Offset and Oblique Liners, in June 2024."
  • NCT04258605 Stopped Aug 2024
    Arthropathy; Traumatic
    "Termination of PMCF study due to product discontinuation."
  • NCT04730739 Phase NA Stopped Jul 2024
    Fracture
    "Product will not be taken to EU, thus no PMCF requirements."
  • NCT05215600 Stopped Apr 2024
    Arthropathy
    "Termination of PMCF study due to product discontinuation."
  • NCT05179005 Stopped Dec 2023
    Rib Fractures
    "Sponsor Terminated"
  • NCT04093700 Stopped Nov 2022
    Labral Tear, Glenoid
    "The Sponsor decided that the CE marking would not be renewed, and therefore there was no longer a need to continue the study as the data was no longer necessary."
  • NCT04348968 Stopped Mar 2021
    Avascular Necrosis of Hip
    "The notified body does not require data anymore and recruitment did not start. The study was thus terminated after approval from the investigator and the local ethical committee."
  • NCT04079114 Stopped Jul 2019
    Avascular Necrosis of Hip
    "Stafit Acetabular System not CE marked anymore"

Active Trials (40 total)

See all 40 active trials

Top Conditions

Avascular necrosis (35) Osteoarthritis (14) Avascular necrosis of hip (9) Osteoarthritis, knee (8) Degenerative disc disease (6) Shoulder arthritis (5) Avascular necrosis of the femoral condyle (4) Knee osteoarthritis (4) Arthritis (3) Bone marrow edema (3)

Top Locations

Philadelphia, United States (29) Indianapolis, United States (19) Louisville, United States (16) Charlotte, United States (13) Columbus, United States (12) Seoul, South Korea (10) Atlanta, United States (10) Cleveland, United States (10) New York, United States (10) Charlottesville, United States (9)